![Albert Tsai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Albert Tsai is Chief Medical Officer at VivaVision Biotech (Zhejiang) Co., Ltd. since 2025.
Formerly, Dr. Tsai was Vice President at PPD, Inc. from 2019 to 2021 and Chief Medical Officer at Zhaoke Ophthalmology Ltd. Education includes an MBA from the University of Southern California and a doctorate from Northwestern University.
Posizioni attive di Albert Tsai
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Albert Tsai
| Società | Posizione | Fine |
|---|---|---|
| PPD, INC. | Corporate Officer/Principal | 01/01/2021 |
| ZHAOKE OPHTHALMOLOGY LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Albert Tsai
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PPD, Inc.
 PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Zhaoke Ophthalmology Ltd.
 Zhaoke Ophthalmology Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies ophthalmic topical drugs | Health Technology |
